| Diabetes tipo 1 NCT07224321 | Fase 2 | Reclutando pacientes |
| Diabetes tipo 1, Diabetes tipo 2 NCT01798914 | no aplica | Ya no disponible |
| Diabetes tipo 1, Diabetes tipo 2 NCT00642616 | Fase 3 | Interrumpido |
| Diabetes tipo 2 NCT01451398 | Fase 3 | Completado |
| Diabetes tipo 1 NCT01544881 | Fase 1 | Completado |
| Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler NCT01490762 | Fase 1 | Completado |
| Diabetes tipo 2 NCT01196104 | Fase 3 | Interrumpido |
| Diabetes tipo 1, Diabetes tipo 2 NCT01201928 | no aplica | Interrumpido |
| Pharmacokinetic Study in Healthy Volunteers NCT01365117 | Fase 1 | Completado |
| Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks NCT00700622 | Fase 3 | Interrumpido |
| Diabetes tipo 2 NCT00570687 | Fase 2 | Completado |
| Asma, Diabetes NCT00673621 | Fase 1 | Completado |
| A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro NCT00662857 | Fase 2 | Completado |
| Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes NCT00308737 | Fase 3 | Completado |
| Diabetes tipo 1, Diabetes tipo 2 NCT00741429 | no aplica | Completado |
| Diabetes NCT00674050 | Fase 1 | Completado |
| Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up NCT00309244 | Fase 3 | Completado |
| Diabetes NCT00642681 | no aplica | Completado |
| Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes NCT00308308 | Fase 3 | Completado |
| Diabetes tipo 2 NCT00332488 | Fase 3 | Completado |
| Diabetes tipo 1, Diabetes tipo 2 NCT00332826 | Fase 3 | Interrumpido |
| Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes NCT00934414 | Fase 2 | Completado |
| Diabetes tipo 2 NCT00511732 | Fase 2 | Completado |
| Diabetes tipo 2 NCT00511602 | Fase 2 | Completado |
| Diabetes tipo 2 NCT00511719 | Fase 2 | Completado |
| Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin NCT00511979 | Fase 1 | Completado |
| Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus NCT00539890 | Fase 3 | Completado |
| Diabetes tipo 1 NCT00539396 | Fase 2 | Completado |